BIOBio Protocol (BIO) Price

1.Project introduction

BIO Protocol aims to revolutionize the biotechnology industry by enabling global patients, scientists, and biotech professionals to collectively fund, develop, and own tokenized biotech projects and intellectual property. Building on the team's experience from Molecule and VitaDAO, BIO leverages decentralized finance, incentive mechanisms, and blockchain-native governance to foster a transparent, collaborative, and efficient on-chain scientific ecosystem. The platform addresses issues of IP ownership, research funding, reproducibility, and collaborative automation through technologies like IP-NFTs, DAOs, and open data frameworks, creating a community-governed engine for progressive biotech advancement.

2.Team introduction

Paul Kohlhaas - Co-founder

https://x.com/paulkhls

Clemens Ortlepp - Co-founder

https://x.com/cl2pp

3.Investment institution

Investors include YZi Labs (formerly Binance Labs), 1kx, Boost VC, and Northpond Ventures. YZi Labs made an undisclosed investment in November 2024, while the IDO/ICO round raised $6.2 million in August 2024.

4.Token application and distribution

Token application

The BIO token is primarily used for protocol governance, including decisions like admitting biotech DAOs to the BIO network, setting terms for DAO and IP-token sales, supporting DAO-backed products/services, metagovernance within biotech DAOs, treasury allocations, and protocol upgrades. It also facilitates staking for veBIO (governance power), provides eligibility for airdrops, access to exclusive launches, and ecosystem participation incentives.

Token distribution

COMMUNITY: 56%

• Community Auction: 20%
• Community Airdrop: 6%
• Ecosystem Incentives: 25%
• Molecule Ecosystem Fund: 5%

INVESTORS (Early Backers): 13.6%

CORE CONTRIBUTORS (Early Contributors): 21.2%

ADVISORS: 4.2%

MOLECULE: 5%